Patent_application_number,Applicant_name,Year_of_application,Patent_system
EP2966981A1,BAYER,2016,EPO
EP2968397A1,MODERNA,2016,EPO
EP2970368A1,BAYER,2016,EPO
EP2970942A1,GLYCOBIA,2016,EPO
EP2971030A2,GLYCOBIA,2016,EPO
EP2971153A1,HARVARD MEDICAL SCHOOL,2016,EPO
EP2975122A2,CHEVRON,2016,EPO
EP2975130A2,BASF,2016,EPO
EP2984162A1,DSM IP ASSETS BV,2016,EPO
EP2986725A1,AGRES LTD [NZ],2016,EPO
EP2990478A1,PROMEGA CORPORATION,2016,EPO
EP2992090A2,BASF,2016,EPO
EP2992102A2,BASF,2016,EPO
EP2992103A2,BASF,2016,EPO
EP2995626A1,CHINA PHARMACEUTICAL UNIVERSITY,2016,EPO
EP2995681A1,UNIV KYUSHU NAT UNIV CORP [JP],2016,EPO
EP2995684A1,UNIV KOREA RES & BUS FOUND [KR],2016,EPO
EP2998393A1,CHEVRON,2016,EPO
EP2998401A2,BASF,2016,EPO
EP3006568A1,CJ CHEILJEDANG CORP,2016,EPO
EP3009516A1,GENECHEM INC,2016,EPO
EP3013971A1,UNIVERSITY OF CALIFORNIA,2016,EPO
EP3029143A1,BASF,2016,EPO
EP3030898A1,GSURF,2016,EPO
EP3056569A2,EVOGENE,2016,EPO
EP3056570A1,BASF,2016,EPO
EP3058078A1,MELT&MARBLE,2016,EPO
EP3059309A1,UNIV KOREA RES & BUS FOUND [KR],2016,EPO
EP3066217A1,UNIV BRITISH COLUMBIA [CA],2016,EPO
EP3066934A1,BASF,2016,EPO
EP3073817A1,CORTEVA,2016,EPO
EP3081642A1,"KYOTO SANGYO UNIVERSITY [JP], HORIBA LTD [JP]",2016,EPO
EP3082405A1,CSIRO,2016,EPO
EP3090041A1,VIRIDOS,2016,EPO
EP3090057A1,UNIV MASSACHUSETTS [US],2016,EPO
EP3099782A2,DSM IP ASSETS BV,2016,EPO
JP2016000048A,DSM IP ASSETS BV,2016,JPO
JP2016002034A,TOKYO UNIVERSITY,2016,JPO
JP2016007154A,KAO CORPORATION,2016,JPO
JP2016013126A,CSIRO,2016,JPO
JP2016028583A,BASF,2016,JPO
JP2016028599A,PROMEGA CORPORATION,2016,JPO
JP2016034258A,KAO CORPORATION,2016,JPO
JP2016042869A,TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY,2016,JPO
JP2016047055A,SANOFI,2016,JPO
JP2016054703A,KAO CORPORATION,2016,JPO
JP2016054715A,CHISSO CORPORATION,2016,JPO
JP2016060743A,REPUBLIC OF KOREA,2016,JPO
JP2016073302A,LUDWIG-MAXIMILIANS-UNIVERSITAT,2016,JPO
JP2016101172A,DU PONT,2016,JPO
JP2016109666A,HIROSHIMA UNIVERSITY,2016,JPO
JP2016112021A,SCRIPPS RESEARCH INSTITUTE,2016,JPO
JP2016119868A,TOYOBO CO LTD,2016,JPO
JP2016129518A,"IKUO NAKAMURA,TOSHIYUKI MORIIZUMI",2016,JPO
JP2016131541A,FUJITA HEALTH UNIVERSITY,2016,JPO
JP2016141678A,HIROSHIMA UNIVERSITY,2016,JPO
JP2016144416A,NIAS,2016,JPO
JP2016146832A,BASF,2016,JPO
JP2016158599A,AJINOMOTO,2016,JPO
JP2016161420A,NIAS,2016,JPO
JP2016163559A,TOYAMA PREFECTURE,2016,JPO
JP2016163562A,BASF,2016,JPO
JP2016165225A,AJINOMOTO,2016,JPO
JP2016168051A,TOYOBO CO LTD,2016,JPO
JP2016171790A,IFF,2016,JPO
JP2016178943A,CHEVRON,2016,JPO
JP2016188251A,KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION,2016,JPO
JP2016192903A,AJINOMOTO,2016,JPO
JP2016195605A,TOKYO UNIVERSITY,2016,JPO
JP2016198075A,PLASMIA BIOTECH,2016,JPO
JP2016202038A,JAIST,2016,JPO
JP2016208993A,DSM IP ASSETS BV,2016,JPO
JP2016214182A,KAO CORPORATION,2016,JPO
JP2016214183A,KAO CORPORATION,2016,JPO
JP2016220683A,BASF,2016,JPO
JP2016500261A,CHEVRON,2016,JPO
JP2016500514A,ROTHAMSTED,2016,JPO
JP2016500698A,BRISTOL-MYERS SQUIBB COMPANY,2016,JPO
JP2016501023A,MERCK,2016,JPO
JP2016501040A,VERDEZYNE INC,2016,JPO
JP2016501530A,GOVERNMENT OF FRANCE,2016,JPO
JP2016502399A,MINERVA BIOTECHNOLOGIES CORPORATION,2016,JPO
JP2016502405A,MERZ PHARMA GMBH AND CO KGAA,2016,JPO
JP2016503648A,HEALTHGEN BIOTECHNOLOGY CO LTD,2016,JPO
JP2016503663A,CHEVRON,2016,JPO
JP2016511003A,BAYER,2016,JPO
JP2016511010A,DU PONT,2016,JPO
JP2016512035A,DSM IP ASSETS BV,2016,JPO
JP2016512047A,AMYRIS,2016,JPO
JP2016514960A,BELLICUM PHARMACEUTICALS INC,2016,JPO
JP2016514964A,BAYER,2016,JPO
JP2016515138A,THE JOHNSON & JOHNSON,2016,JPO
JP2016517276A,HARVARD MEDICAL SCHOOL,2016,JPO
JP2016517690A,CAMBREX IEP GMBH,2016,JPO
JP2016518108A,BASF,2016,JPO
JP2016518114A,GLYCOBIA,2016,JPO
JP2016518825A,GLYCOBIA,2016,JPO
JP2016519077A,SAFEWHITE,2016,JPO
JP2016519577A,"ZACHARY Q BECK,JEFFREY W MUNOS,DEREK H WELLS,JIAN YAO",2016,JPO
JP2016519650A,REGENERON PHARMA,2016,JPO